Irum Khan

8PUBLICATIONS
41CO-AUTHORS
Haematological tumoursGene and molecular therapyAir pollution processes and air quality measurementMedical molecular engineering of nucleic acids and proteinsAutonomous agents and multiagent systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 15, 2026
PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.

|Oct 16, 2025
Impact of modernizing eligibility criteria on enrollment and representation in acute myeloid leukemia clinical trials.

Andrew Hantel, Yating Wang, Angel Cronin

|May 29, 2024
Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia.

Andrew Palmer, Garth Rauscher, Ivy Abraham

|Aug 22, 2023
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.

I Khan, A Kaempf, S Raghuwanshi

|May 04, 2022
The antagonistic duality of NPM1 mutations in AML.

Irum Khan, Andrei L Gartel

|Jan 21, 2022
Structural racism is a mediator of disparities in acute myeloid leukemia outcomes.

Ivy Elizabeth Abraham, Garth H Rauscher, Anand Ashwin Patel

Pageof 2

Frequent Collaborators

3 joint publications

Anand Ashwin Patel

2 joint publications

Carlos Galvez

1 joint publications

S Raghuwanshi

1 joint publications

M Chesnokov